Adult female acne: A new paradigm

Journal of the European Academy of Dermatology and Venereology

Volumn 27, Issue 9, 2013, Pages 1063-1070

  Dreno B ^a   Layton, A ^b   Zouboulis, C C ^c   Lopez Estebaranz J L ^d   Zalewska Janowska, A ^e   Bagatin, E ^f   Zampeli, V A ^c   Yutskovskaya, Y ^g   Harper, J C ^h  

^a HÔTEL DIEU   (France)

^b HARROGATE AND DISTRICT NHS FOUNDATION TRUST   (United Kingdom)

^c DESSAU MEDICAL CENTER   (Germany)

^d HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

^e MEDICAL UNIVERSITY OF LODZ   (Poland)

^f FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^g PACIFIC STATE MEDICAL UNIVERSITY   (Russian Federation)

^h UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZELAIC ACID; BENZOYL PEROXIDE; CLINDAMYCIN; COSMETIC; CYPROTERONE ACETATE; DESOGESTREL; ERYTHROMYCIN; ETHINYLESTRADIOL; GESTODENE; ISOTRETINOIN; LEVONORGESTREL; NORGESTIMATE; ORAL CONTRACEPTIVE AGENT; PREDNISONE; RETINOID; SPIRONOLACTONE; TETRACYCLINE DERIVATIVE; ZINC DERIVATIVE;

ACNE; ADJUVANT THERAPY; ADULT; ADULT FEMALE ACNE; ANTIBIOTIC RESISTANCE; ANTIINFLAMMATORY ACTIVITY; BLEACHING; BREAST TENDERNESS; CHLOASMA; COMEDO; DIZZINESS; EDEMA; FATIGUE; FEMALE; FLUID RETENTION; HEADACHE; HORMONAL THERAPY; HUMAN; HYPERKALEMIA; MAINTENANCE THERAPY; MENSTRUAL IRREGULARITY; MENSTRUATION DISORDER; MONOTHERAPY; MORPHOLOGICAL TRAIT; NAUSEA; PAPULE; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT PREFERENCE; PHOTOSENSITIVITY; PHOTOTHERAPY; PHYSICAL EXAMINATION; POSTINFLAMMATORY HYPERPIGMENTATION; PREGNANCY; PRIORITY JOURNAL; PUSTULE; REVIEW; SCAR FORMATION; SEBUM SECRETION; SIDE EFFECT; SKIN ABRASION; SKIN NODULE; SYSTEMIC THERAPY; TERATOGENICITY; TREATMENT DURATION; VOMITING;

ACNE VULGARIS; ADULT; COMBINED MODALITY THERAPY; FEMALE; HUMANS;

EID: 84881165408     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.12061     Document Type: Review

References (75)

1. Williams C, Layton AM,. Persistent acne in women: implications for the patient and for therapy. Am J Clin Dermatol 2006; 7: 281-290.
2. Rivera R, Guerra A,. Management of acne in women over 25 years of age. Actas Dermosifiliogr 2009; 100: 33-37.
3. Capitanio B, Sinagra JL, Bordignon V, et al. Underestimated clinical features of postadolescent acne. J Am Acad Dermatol 2010; 63: 782-788.
4. Bataille V, Snieder H, MacGregor AJ, et al. The influence of genetics and environmental factors in the pathogenesis of acne: a twin study of acne in women. J Invest Dermatol 2002; 119: 1317-1322.
5. Goulden V, McGeown CH, Cunliffe WJ,. The familial risk of adult acne: a comparison between first-degree relatives of affected and unaffected individuals. Br J Dermatol 1999; 141: 297-300.
6. Herane MI, Ando I,. Acne in infancy and acne genetics. Dermatology 2003; 206: 24-28.
7. Zouboulis CC, Piquero-Martin J,. Update and future of systemic acne treatment. Dermatology 2003; 206: 37-53.
8. Abulnaja KO,. Changes in the hormone and lipid profile of obese adolescent Saudi females with acne vulgaris. Braz J Med Biol Res 2009; 42: 501-505.
9. Bowe WP, Joshi SS, Shalita AR,. Diet and acne. J Am Acad Dermatol 2010; 63: 124-141.
10. Zouboulis CC, Eady A, Philpott M, et al. What is the pathogenesis of acne? Exp Dermatol 2005; 14: 143-152.
11. Cappel M, Mauger D, Thiboutot D,. Correlation between serum levels of insulin-like growth factor 1, dehydroepiandrosterone sulfate, and dihydrotestosterone and acne lesion counts in adult women. Arch Dermatol 2005; 141: 333-338.
12. Smith RN, Braue A, Varigos GA, et al. The effect of a low glycemic load diet on acne vulgaris and the fatty acid composition of skin surface triglycerides. J Dermatol Sci 2008; 50: 41-52.
13. Smith RN, Mann N, Makelainen H, et al. A pilot study to determine the short-term effects of a low glycemic load diet on hormonal markers of acne: a nonrandomized, parallel controlled feeding trial. Mol Nutr Food Res 2008; 52: 718-726.
14. Smith RN, Mann NJ, Braue A, et al. The effect of a high-protein, low glycemic-load diet versus a conventional, high glycemic-load diet on biochemical parameters associated with acne vulgaris: a randomized, investigator-masked, controlled trial. J Am Acad Dermatol 2007; 57: 247-256.
15. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19: 41-47.
16. Choi CW, Lee DH, Kim HS, et al. The clinical features of late onset acne compared with early onset acne in women. J Eur Acad Dermatol Venereol 2011; 25: 454-461.
17. Thomas B, Tan JKL,. Adherence optimization in acne management. Skin Ther Lett 2011; 7: 1-3.
18. Savage LJ, Layton AM,. Treating acne vulgaris: systemic, local and combination therapy. Expert Rev Clin Pharmacol 2010; 13: 563-580.
19. Johnson BA, Nunley JR,. Use of systemic agents in the treatment of acne vulgaris. Am Fam Physician 2000; 62: 1823-1830.
20. Gollnick HP, Krautheim A,. Topical treatment in acne: current status and future aspects. Dermatology 2003; 206: 29-36.
21. Shalita A, Weiss JS, Chalker DK, et al. A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: a multicenter trial. J Am Acad Dermatol 1996; 34: 482-485.
22. Dunlap FE, Mills OH, Tuley MR, et al. Adapalene 0.1% gel for the treatment of acne vulgaris: its superiority compared to tretinoin 0.025% cream in skin tolerance and patient preference. Br J Dermatol 1998; 139 (Suppl 52): 17-22.
23. Thielitz A, Abdel-Naser MB, Fluhr JW, et al. Topical retinoids in acne - an evidence-based overview. J Dtsch Dermatol Ges 2008; 6: 1023-1031.
24. Schaefer H,. Penetration and percutaneous absorption of topical retinoids. A review. Skin Pharmacol 1993; 6 (Suppl 1): 17-23.
25. Merkviladze N, Gaidamashvili T, Tushurashvili P, et al. The efficacy of topical drugs in treatment of noninflammatory acne vulgaris. Georgian Med News 2010; 186: 46-50.
26. Thiboutot D,. Versatility of azelaic acid 15% gel in treatment of inflammatory acne vulgaris. J Drugs Dermatol 2008; 7: 13-16.
27. Webster G,. Combination azelaic acid therapy for acne vulgaris. J Am Acad Dermatol 2000; 43: S47-50.
28. Gollnick HP, Graupe K, Zaumseil RP,. Azelaic acid 15% gel in the treatment of acne vulgaris Combined results of two double-blind clinical comparative studies. J Dtsch Dermatol Ges 2004; 2: 841-847.
29. Kircik LH,. Efficacy and Safety of Azelaic Acid (AzA) Gel 15% in the Treatment of Post-Inflammatory Hyperpigmentation and Acne: A 16-Week, Baseline-Controlled Study. J Drugs Dermatol 2011; 10: 586-590.
30. Fluhr JW, Degitz K,. Antibiotics, azelaic acid and benzoyl peroxide in topical acne therapy. J Dtsch Dermatol Ges 2010; 8 (Suppl 1): S24-30.
31. Toyoda M, Morohashi M,. An overview of topical antibiotics for acne treatment. Dermatology 1998; 196: 130-134.
32. Ghods M, Alikhan A, Feldman SR,. The role of dapsone gel in the acne armamentarium. Skin and Aging 2010; 18: 36-39.
33. Guay DR,. Topical clindamycin in the management of acne vulgaris. Expert Opin Pharmacother 2007; 8: 2625-2664.
34. Thiboutot D, Gollnick H, Bettoli V, et al. New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group. J Am Acad Dermatol 2009; 60: S1-50.
35. Tanghetti EA, Popp KF,. A current review of topical benzoyl peroxide: new perspectives on formulation and utilization. Dermatol Clin 2009; 27: 17-24.
36. Dreno B,. Topical antibacterial therapy for acne vulgaris. Drugs 2004; 64: 2389-2397.
37. Zouboulis CC, Fischer TC, Wohlrab J, et al. Study of the efficacy, tolerability, and safety of 2 fixed-dose combination gels in the management of acne vulgaris. Cutis 2009; 84: 223-229.
38. Gollnick HP, Draelos Z, Glenn MJ, et al. Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients. Br J Dermatol 2009; 161: 1180-1189.
39. Kircik LH, Peredo MI, Bucko AD, et al. Safety of a novel gel formulation of clindamycin phosphate 1.2%-tretinoin 0.025%: results from a 52-week open-label study. Cutis 2008; 82: 358-366.
40. Ghali F, Kang S, Leyden J, et al. Changing the face of acne therapy. Cutis 2009; 83: 4-15.
41. Thiboutot DM,. Acne. An overview of clinical research findings. Dermatol Clin 1997; 15: 97-109.
42. Ochsendorf F,. Systemic antibiotic therapy of acne vulgaris. J Dtsch Dermatol Ges 2006; 4: 828-841.
43. Newman MD, Bowe WP, Heughebaert C, et al. Therapeutic considerations for severe nodular acne. Am J Clin Dermatol 2011; 12: 7-14.
44. Eady EA, Cove JH, Holland KT, et al. Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure. Br J Dermatol 1989; 121: 51-57.
45. Niebyl JR,. Antibiotics and other anti-infective agents in pregnancy and lactation. Am J Perinatol 2003; 20: 405-414.
46. Thiboutot D,. Hormones and acne: pathophysiology, clinical evaluation, and therapies. Semin Cutan Med Surg 2001; 20: 144-153.
47. Gollnick H, Cunliffe W, Berson D, et al. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol 2003; 49: S1-37.
48. Zouboulis CC, Rabe T,. [Hormonal antiandrogens in acne treatment]. J Dtsch Dermatol Ges 2010; 8 (Suppl 1): S60-S74.
49. Shaw JC,. Low-dose adjunctive spironolactone in the treatment of acne in women: a retrospective analysis of 85 consecutively treated patients. J Am Acad Dermatol 2000; 43: 498-502.
50. Tan JK,. New developments in hormonal therapy for acne. Skin Ther Lett 2007; 12: 1-3.
51. Arowojolu AO, Gallo MF, Lopez LM, et al. Combined oral contraceptive pills for treatment of acne. Cochrane Database Syst Rev 2009; 3: CD004425.
52. Kimball AB,. Advances in the treatment of acne. J Reprod Med 2008; 53: 742-752.
53. Dreno B, Bettoli V, Ochsendorf F, et al. An expert view on the treatment of acne with systemic antibiotics and/or oral isotretinoin in the light of the new European recommendations. Eur J Dermatol 2006; 16: 565-571.
54. Layton AM, Dreno B, Gollnick HP, et al. A review of the European Directive for prescribing systemic isotretinoin for acne vulgaris. J Eur Acad Dermatol Venereol 2006; 20: 773-776.
55. Zane LT, Leyden WA, Marqueling AL, et al. A population-based analysis of laboratory abnormalities during isotretinoin therapy for acne vulgaris. Arch Dermatol 2006; 142: 1016-1022.
56. Leyden JJ, James WD,. Staphylococcus aureus infection as a complication of isotretinoin therapy. Arch Dermatol 1987; 123: 606-8.
57. DiGiovanna JJ,. Systemic retinoid therapy. Dermatol Clin 2001; 19: 161-167.
58. Rademaker M,. Adverse effects of isotretinoin: A retrospective review of 1743 patients started on isotretinoin. Australas J Dermatol 2010; 51: 248-253.
59. Malvasi A, Tinelli A, Buia A, et al. Possible long-term teratogenic effect of isotretinoin in pregnancy. Eur Rev Med Pharmacol Sci 2009; 13: 393-396.
60. Dreno B, Moyse D, Alirezai M, et al. Multicenter randomized comparative double-blind controlled clinical trial of the safety and efficacy of zinc gluconate versus minocycline hydrochloride in the treatment of inflammatory acne vulgaris. Dermatology 2001; 203: 135-140.
61. Stephan F, Revuz J,. [Zinc salts in dermatology]. Ann Dermatol Venereol 2004; 131: 455-460.
62. Hamilton FL, Car J, Lyons C, et al. Laser and other light therapies for the treatment of acne vulgaris: systematic review. Br J Dermatol 2009; 160: 1273-1285.
63. Haedersdal M, Togsverd-Bo K, Wulf HC,. Evidence-based review of lasers, light sources and photodynamic therapy in the treatment of acne vulgaris. J Eur Acad Dermatol Venereol 2007; 22: 267-278.
64. Ong MWS, Bashir S,. Fractional Laser Resurfacing for Acne Scars: A Review. Br J Dermatol 2012; 166: 1160-1169.
65. Dreno B, Fischer TC, Perosino E, et al. Expert opinion: efficacy of superficial chemical peels in active acne management - what can we learn from the literature today? Evidence-based recommendations J Eur Acad Dermatol Venereol 2011; 25: 695-704.
66. Kessler E, Flanagan K, Chia C, et al. Comparison of alpha- and beta-hydroxy acid chemical peels in the treatment of mild to moderately severe facial acne vulgaris. Dermatol Surg 2008; 34: 45-50; discussion 1.
67. Steventon K,. Expert opinion and review article: The timing of comedone extraction in the treatment of premenstrual acne - a proposed therapeutic approach. Int J Cosmet Sci 2011; 33: 99-104.
68. Bagatin E, dos Santos Guadanhim LR, Yarak S, et al. Dermabrasion for acne scars during treatment with oral isotretinoin. Dermatol Surg 2010; 36: 483-489.
69. Ayhan S, Baran CN, Yavuzer R, et al. Combined chemical peeling and dermabrasion for deep acne and posttraumatic scars as well as aging face. Plast Reconstr Surg 1998; 102: 1238-1246.
70. Dreno B, Thiboutot D, Gollnick H, et al. Large-scale worldwide observational study of adherence with acne therapy. Int J Dermatol 2010; 49: 448-456.
71. Ascenso A, Marques HC,. Acne in the adult. Mini Rev Med Chem 2009; 9: 1-10.
72. Yentzer BA, Alikhan A, Teuschler H, et al. An exploratory study of adherence to topical benzoyl peroxide in patients with acne vulgaris. J Am Acad Dermatol 2009; 60: 879-880.
73. Skinoren Core Data Sheet version 2010
74. Gollnick HPM, Graupe K, Zaumseil RP,. Comparison of combined azelaic acid cream plus oral minocycline with oral isotretinoin in severe acne. Eur J Dermatol 2001; 11: 538-544.
75. Sørensen HT, Skriver MV, Pedersen L, Larsen H, Ebbesen F, Schønheyder HC,. Risk of infantile hypertrophic pyloric stenosis after maternal postnatal use of macrolides. Scand J Infect Dis 2003; 35: 104-106.